Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: A meta-analysis

World Journal of Gastroenterology

Volumn 19, Issue 28, 2013, Pages 4607-4615

  Huang, Wei ^a   Altaf, Kiran ^b   Jin, Tao ^a   Xiong, Jun Jie ^a   Wen, Li ^b   Javed, Muhammad A ^b   Johnstone, Marianne ^b   Xue, Ping ^a   Halloran, Christopher M ^b   Xia, Qing ^a  

^a SICHUAN UNIVERSITY   (China)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Acute pancreatitis; Acute Physiology and Chronic Health Evaluation II score; C reactive protein; Meta analysis; Urinary trypsinogen activation peptide

Indexed keywords

C REACTIVE PROTEIN; TRYPSINOGEN ACTIVATION PEPTIDE;

ACUTE PANCREATITIS; APACHE; ARTICLE; DIAGNOSTIC VALUE; DISEASE SEVERITY; GENETIC HETEROGENEITY; HUMAN; META ANALYSIS; PROGNOSIS; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 84880840204     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i28.4607     Document Type: Article

References (44)

1. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA 2004; 291: 2865-2868 [PMID: 15199038 DOI: 10.1001/ jama.291.23.2865]
2. Gurusamy KS, Farouk M, Tweedie JH. UK guidelines for management of acute pancreatitis: is it time to change? Gut 2005; 54: 1344-1345 [PMID: 16099804 DOI: 10.1136/ gut.2005.071076]
3. Fisher JM, Gardner TB. The "golden hours" of management in acute pancreatitis. Am J Gastroenterol 2012; 107: 1146-1150 [PMID: 22858994 DOI: 10.1038/ajg.2012.91]
4. Al-Bahrani AZ, Ammori BJ. Clinical laboratory assessment of acute pancreatitis. Clin Chim Acta 2005; 362: 26-48 [PMID: 16024009 DOI: 10.1016/j.cccn.2005.06.008]
5. Bollen TL, Singh VK, Maurer R, Repas K, van Es HW, Banks PA, Mortele KJ. A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. Am J Gastroenterol 2012; 107: 612-619 [PMID: 22186977 DOI: 10.1038/ajg.2011.438]
6. Dambrauskas Z, Gulbinas A, Pundzius J, Barauskas G. Value of the different prognostic systems and biological markers for predicting severity and progression of acute pancreatitis. Scand J Gastroenterol 2010; 45: 959-970 [PMID: 20367283 DOI: 10.3109/00365521003770244]
7. Mounzer R, Langmead CJ, Wu BU, Evans AC, Bishehsari F, Muddana V, Singh VK, Slivka A, Whitcomb DC, Yadav D, Banks PA, Papachristou GI. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology 2012; 142: 1476-1482; quiz e15-16 [PMID: 22425589 DOI: 10.1053/ j.gastro.2012.03.005]
8. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O'Neill J, Blumgart LH. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978; 65: 337-341 [PMID: 348250]
9. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet 1989; 2: 201-205 [PMID: 2568529]
10. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Localio SA. Objective early identification of severe acute pancreatitis. Am J Gastroenterol 1974; 61: 443-451 [PMID: 4835417]
11. Pezzilli R, Zerbi A, Di Carlo V, Bassi C, Delle Fave GF. Practical guidelines for acute pancreatitis. Pancreatology 2010; 10: 523-535 [PMID: 20975316 DOI: 10.1159/000314602]
12. Gaiser S, Daniluk J, Liu Y, Tsou L, Chu J, Lee W, Longnecker DS, Logsdon CD, Ji B. Intracellular activation of trypsinogen in transgenic mice induces acute but not chronic pancreatitis. Gut 2011; 60: 1379-1388 [PMID: 21471572 DOI: 10.1136/gut.2010.226175]
13. Dawra R, Sah RP, Dudeja V, Rishi L, Talukdar R, Garg P, Saluja AK. Intra-acinar trypsinogen activation mediates early stages of pancreatic injury but not inflammation in mice with acute pancreatitis. Gastroenterology 2011; 141: 2210-2217. e2 [PMID: 21875495 DOI: 10.1053/j.gastro.2011.08.033]
14. Borgström A, Appelros S, Müller CA, Uhl W, Büchler MW. Role of activation peptides from pancreatic proenzymes in the diagnosis and prognosis of acute pancreatitis. Surgery 2002; 131: 125-128 [PMID: 11854688]
15. Gudgeon AM, Heath DI, Hurley P, Jehanli A, Patel G, Wilson C, Shenkin A, Austen BM, Imrie CW, Hermon-Taylor J. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335: 4-8 [PMID: 1967341]
16. Heath DI, Wilson C, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1994; 35: 1311-1315 [PMID: 7525422]
17. Frossard JL. Trypsin activation peptide (TAP) in acute pancreatitis: from pathophysiology to clinical usefulness. JOP 2001; 2: 69-77 [PMID: 11867866]
18. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590 [PMID: 8489394]
19. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003; 326: 41-44 [PMID: 12511463]
20. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56: 1129-1135 [PMID: 14615004]
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560 [PMID: 12958120 DOI: 10.1136/bmj.327.7414.557]
22. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005; 58: 882-893 [PMID: 16085191 DOI: 10.1016/ j.jclinepi.2005.01.016]
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188 [PMID: 3802833]
24. Lempinen M, Stenman UH, Puolakkainen P, Hietaranta A, Haapiainen R, Kemppainen E. Sequential changes in pancreatic markers in acute pancreatitis. Scand J Gastroenterol 2003; 38: 666-675 [PMID: 12825877]
25. Heath DI, Cruickshank A, Gudgeon AM, Jehanli A, Shenkin A, Imrie CW. The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis. Pancreas 1995; 10: 347-353 [PMID: 7540760]
26. Pezzilli R, Venturi M, Morselli-Labate AM, Ceciliato R, Lamparelli MG, Rossi A, Moneta D, Piscitelli L, Corinaldesi R. Serum trypsinogen activation peptide in the assessment of the diagnosis and severity of acute pancreatic damage: a pilot study using a new determination technique. Pancreas 2004; 29: 298-305 [PMID: 15502646]
27. Kemppainen E, Mayer J, Puolakkainen P, Raraty M, Slavin J, Neoptolemos JP. Plasma trypsinogen activation peptide in patients with acute pancreatitis. Br J Surg 2001; 88: 679-680 [PMID: 11350439 DOI: 10.1046/j.1365-2168.2001.01747.x]
28. Sáez J, Martínez J, Trigo C, Sánchez-Payá J, Compañy L, Laveda R, Griñó P, García C, Pérez-Mateo M. Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis. World J Gastroenterol 2005; 11: 7261-7265 [PMID: 16437625]
29. Banks PA, Carr-Locke DL, Slivka A, Van Dam J, Lichtenstein DR, Hughes M. Urinary trypsinogen activation peptides (TAP) are not increased in mild ERCP-induced pancreatitis. Pancreas 1996; 12: 294-297 [PMID: 8830337]
30. Pezzilli R, Mariani A, Gabbrielli A, Morselli-Labate AM, Barassi A. Serum and urine trypsinogen activation peptide in assessing post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas 2010; 39: 108-110 [PMID: 20019567 DOI: 10.1097/MPA.0b013e3181bab5fb]
31. Tenner S, Fernandez-del Castillo C, Warshaw A, Steinberg W, Hermon-Taylor J, Valenzuela JE, Hariri M, Hughes M, Banks PA. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis. Int J Pancreatol 1997; 21: 105-110 [PMID: 9209951]
32. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955-1960 [PMID: 10859041]
33. Khan Z, Vlodov J, Horovitz J, Jose RM, Iswara K, Smotkin J, Brown A, Tenner S. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study. Am J Gastroenterol 2002; 97: 1973-1977 [PMID: 12190163 DOI: 10.1111/j.1572-0241.2002.05953.x]
34. Liu ZS, Jiang CQ, Qian Q, Sun Q, Fan LF, Ai ZL. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide. Hepatobiliary Pancreat Dis Int 2002; 1: 285-289 [PMID: 14612286]
35. Lempinen M, Stenman UH, Finne P, Puolakkainen P, Haapiainen R, Kemppainen E. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis. J Surg Res 2003; 111: 267-273 [PMID: 12850473]
36. Sáez J, Martínez J, Trigo C, Sánchez-Payá J, Griñó P, Compañy L, Laveda R, Penalva JC, García C, Pérez-Mateo M. A comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis. Pancreas 2004; 29: e9-14 [PMID: 15211118]
37. Johnson CD, Lempinen M, Imrie CW, Puolakkainen P, Kemppainen E, Carter R, McKay C. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br J Surg 2004; 91: 1027-1033 [PMID: 15286966 DOI: 10.1002/ bjs.4612]
38. Huang QL, Qian ZX, Li H. A comparative study of the urinary trypsinogen-2, trypsinogen activation peptide, and the computed tomography severity index as early predictors of the severity of acute pancreatitis. Hepatogastroenterology 2010; 57: 1295-1299 [PMID: 21410075]
39. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-111 [PMID: 23100216 DOI: 10.1136/gutjnl-2012-302779]
40. Papachristou GI, Clermont G, Sharma A, Yadav D, Whitcomb DC. Risk and markers of severe acute pancreatitis. Gastroenterol Clin North Am 2007; 36: 277-296, viii [PMID: 17533079 DOI: 10.1016/j.gtc.2007.03.003]
41. Lippi G, Valentino M, Cervellin G. Laboratory diagnosis of acute pancreatitis: in search of the Holy Grail. Crit Rev Clin Lab Sci 2012; 49: 18-31 [PMID: 22339380 DOI: 10.3109/10408 363.2012.658354]
42. Hurley PR, Cook A, Jehanli A, Austen BM, Hermon-Taylor J. Development of radioimmunoassays for free tetra-Laspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988; 111: 195-203 [PMID: 3397545]
43. Ansar W, Ghosh S. C-reactive protein and the biology of disease. Immunol Res 2013; 56: 131-142 [PMID: 23371836 DOI: 10.1007/s12026-013-8384-0]
44. Dellinger EP, Forsmark CE, Layer P, Lévy P, Maraví-Poma E, Petrov MS, Shimosegawa T, Siriwardena AK, Uomo G, Whitcomb DC, Windsor JA. Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg 2012; 256: 875-880 [PMID: 22735715 DOI: 10.1097/SLA.0b013e318256f778]